Navigation Links
Burrill & Company CEO and Genzyme Executive Join BVGH Board of Directors
Date:10/11/2010

f the Board of various not-for-profit organizations including Bay Area Science Infrastructure Consortium (BASIC), The Kellogg Center for Biotechnology, the MIT Center for Biomedical Innovation, the National Health Museum, BioAg Gateway - City of Madison, University of Wisconsin College of Agriculture & Life Sciences, and the Scientific American Board of Advisors.

Geraghty is Senior Vice President of Genzyme Corporation and has played a leading role at the biotechnology company for over a decade.  He was President of Genzyme Europe from 1998-2002 and General Manager of Genzyme's cardiovascular business from 2003-2007.  He oversees Genzyme's strategic initiatives in emerging markets and has led many of the Company's largest transactions.  

Geraghty also oversees Genzyme's Humanitarian Assistance for Neglected Diseases program, under which Genzyme helps develop innovative therapeutic programs on a non-commercial basis. He has structured Genzyme's partnerships with Medicines for Malaria Venture, Brazil's Oswaldo Cruz Institute, and India's International Center for Genetic Engineering and Biotechnology. He served as Co-Chair of the Executive Committee for BIO 2007 and was a Steering Committee member of BVGH'S 2010 Partnering for Global Health Forum.  In addition to his membership on BVGH's Board, he serves as a Director of GTC Biotherapeutics (formerly Genzyme Transgenics Corporation), where he was Chairman and President and CEO, and of Bluebird Bio.

"Adding Steve Burrill and Jim Geraghty to our Board of Directors brings additional industrial and investor expertise to BVGH," says Melinda Moree, Chief Executive Officer of BVGH. "At a time when there is considerable activity in global health, it is critical that work aimed at incentivizing companies to work on new drugs, vaccines, and diagnostics for people in poor countries be grounded in the realities of companies and the investment community."

About BIO Ventures fo
'/>"/>

SOURCE BIO Ventures for Global Health
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Shawn Cross Joins Burrill Merchant Banking
2. Burrill & Company Invests in Taiwan Liposome Company
3. Joao Paulo Baptista Joins Burrill & Company
4. CEO of Burrill & Company to Speak at BioConference Live Slated for November 17th and 18th
5. Burrill & Company and WR Hambrecht + Co to Collaborate on OpenIPO(R) Transactions
6. Shawn Cross Appointed CEO of Burrill Merchant Banking Group
7. Burrill & Company Responds to Recent Press Coverage About Biopark Investment at Elk Run
8. CardioWest™ Artificial Heart Approved For Highest Reimbursement in CMS History : Plus Up To $53,000 New Technology Add-on Payments
9. 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis
10. Bruker Introduces HyperQuant™, a Unique Bench-Top NMR Reader to Quantify Hyperpolarization
11. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... two years of the Governor's Business Plan Contest , the ... edge of its respective industry. This year's field of 27 finalists ... by start ups like Mithridion, Inc., the 2005 winner, and ... , ,As is the custom, the winner will be announced on ...
... , Wis. - Ralph Kauten is taking direct aim ... just passed an early test. , ,Kauten, CEO of ... initial screening of its PreserveX Polymeric Micelles, a core product. ... that enter the body and is used to determine whether ...
... Madison, Wis. - As part of its $6 ... $400 million to extend coverage to customers in Wisconsin and ... continues from 2005, when Cingular invested more $300 million in ... between Illinois and Wisconsin. , ,Since the start of 2006, ...
Cached Biology Technology:Business plan finalists offer peek into entrepreneurial future 2Business plan finalists offer peek into entrepreneurial future 3Business plan finalists offer peek into entrepreneurial future 4QBI's PreserveX product passes initial test 2QBI's PreserveX product passes initial test 3
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 /PRNewswire/ ... ) has announced the addition of the ... report to their offering. ... This insight provides an overview of the ... Watermarking aims to control and monitor piracy ...
(Date:12/19/2014)... , Dec. 18, 2014  23andMe, Inc., the ... a study that pinpoints fine-scale differences in genetic ancestry ... . Since immigrants first arrived more ... States has served as a meeting place ... American history and the ongoing mixing of peoples with ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Practices (GCP) audit to confirm its adherence to ... This accomplishment enables HITLAB to conduct regulated smart ... highest principles for patient safety and research quality. ... healthcare access, quality, and delivery with innovative technology," ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... Nearctic deposited in the United States National Museum of ... Collection of Insects, researchers have found 16 new species ... seven new species. The new species are described ... Species, and a Key of the Charipinae (Hymenoptera: Cynipoidea: ...
... nucleus. In this state it synthesises proteins and, even though ... fact its structure is governed by precise rules that are ... studied DNA by observing it experimentally with a variety of ... silico, that is to say, the study of DNA by ...
... century writer Adam Smith provided a workable metaphor for the ... of Nations," he argued that even as individuals strive, through ... contribute---as if under the influence of a "hidden hand"---to an ... physicist and alive in the 21st century he might be ...
Cached Biology News:25 years of DNA on the computer 2The entropy of nations 2The entropy of nations 3The entropy of nations 4
... Large (Klenow) Fragment, Exonuclease Minus, is a ... 5´→3´ and the 3´→5´ exonuclease activities present ... (1,2). It is used for random primer ... (5). Klenow Fragment, Exonuclease Minus, will leave ...
... 8-iso PGE2 is one of several isoprostanes ... is a potent renal vasoconstrictor in the rat. ... with IC50 values of 0.5 and 5 µM, ... the rat at a concentration of 4 mg/kg/min, ...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
... offers both high-speed and high-volume versatility ... rotor options, making it ideal for a ... Versatility , High-speed (up to 15,000 ... high-volume (4 x 250mL) swinging bucket rotors ...
Biology Products: